Skip to content

Zidovudine

Zidovudine (Combivir) appears in two listed combination tablets, the named brand and Retrovir. Both are used in HIV-1 management, but their additional active ingredients differ. The complete formulation is therefore central to understanding each product. Listed products differ in ingredient profile, form, strength, and pack size.

Combivir

Human Immunodeficiency Virus 1 (hiv-1) Infection

150mg + 300mg

Indicated to address systemic viral load to manage immune defense levels and target retroviral reverse transcription.

From$1.81/ tabletView

Retrovir

Human Immunodeficiency Virus 1 (hiv-1) Infection

100mg · 300mg

Developed to mitigate retroviral progression to support CD4 cell count and target viral DNA polymerase.

From$0.73/ tabletView

How does zidovudine work?

A nucleoside reverse transcriptase inhibitor, zidovudine interrupts an enzyme HIV uses to copy its genetic material. Both tablets form part of HIV Management, with their combination ingredients defining the broader regimen.

Important safety information for Zidovudine

Information about Zidovudine on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.